REGENERON PHARMACEUTICALS, INC.
Latest Filing: Apr 29, 2026 • 25 Total Filings
Total Assets
2026
$40.87B
Total Revenue
2026
$3.61B
Net Income
2026
$727.20M
Operating Cash Flow
2026
$1.08B
549300RCBFWIRX3HYQ56ACTIVE100% match confidenceUS-NY

Identity

Legal Address

C/O C T CORPORATION SYSTEM
28 LIBERTY ST.
NEW YORK, US-NY
10005 US

HQ Address

777 OLD SAW MILL RIVER ROAD
TARRYTOWN, US-NY
10591 US

Category

GENERAL

Registration

Status
ISSUED
Initial
Sep 10, 2013
Next Renewal
Dec 1, 2026
Managing LOU
5493001KJTIIGC8Y1R12

Corporate Structure

This Entity

REGENERON PHARMACEUTICALS, INC.

549300RC…